Cargando…
Transient Leukopenia Induced by Combination Therapy for Severe SARS-CoV-2 Pneumonia
Treatment strategies for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to be heavily researched and ever-changing. Recent data has suggested that combination therapy with dexamethasone, remdesivir and baricitinib could decrease the severity and length of illness...
Autores principales: | Sullivan, Sierra, Leelaviwat, Natnicha, Davalos, Jesus, Evans, Abbie, Abdelnabi, Mahmoud, Mittal, Neha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678126/ https://www.ncbi.nlm.nih.gov/pubmed/36415839 http://dx.doi.org/10.12890/2022_003636 |
Ejemplares similares
-
Transient leukopenia induced by combination therapy for severe SARS-CoV-2 pneumonia
por: Sullivan, S, et al.
Publicado: (2023) -
Refractory Shock Secondary to Denosumab-induced Severe Hypocalcaemia
por: Eshak, Nouran, et al.
Publicado: (2022) -
Contrast medium‐induced transient severe leukopenia
por: Hongo, Takashi, et al.
Publicado: (2017) -
Pre‐bariatric surgery acute kidney injury: Can this be prevented?
por: Leelaviwat, Natnicha, et al.
Publicado: (2023) -
IVABRADINE EFFECTS ON COVID-19 INDUCED POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023)